REFERENCES
1. Vipudhamorn W, Juthasilaparut T, Sutharat P, et al. Unraveling the enigma of sclerosing encapsulating peritonitis: a comprehensive review. Ann Coloproctol. 2025;41:175-89.
2. Mekann Bouv-Hez M, Charissoux A, Bouvier S, Mathonnet M, Christou N. From abdominal pain to a diagnosis of primary sclerosing encapsulating peritonitis and its management, a case report. Acta Chir Belg. 2021;122:420-3.
3. Kang D, Sun L, Zhang X. Research progress of tamoxifen in the treatment of encapsulated peritoneal sclerosis. New Med. 2024;55:30-4. Available from: https://qikan.cqvip.com/Qikan/Article/Detail?id=7111267754 [Last accessed on 3 Jun 2026].
4. Mccrory MA, Heard MA, Wright JG, Roche KF. Sclerosing encapsulating peritonitis: a rare cause of bowel obstruction. Am Surg. 2023;89:3496-8.
5. Gupta S, Woodrow G. Successful treatment of fulminant encapsulating peritoneal sclerosis following fungal peritonitis with tamoxifen. Clin Nephrol. 2007;68:125-9.
6. Kim BS, Choi HY, Ryu D, et al. Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea. Yonsei Med J. 2005;46:104.
7. Aliyev V, Yagi S, Hammad A, et al. Sclerosing encapsulating peritonitis after living-donor liver transplantation: a case series, Kyoto experience. Ann Hepatobiliary Pancreat Surg. 2018;22:144.
8. Ni Z, Chen Q, Huang C, Wang S, Huang Q. Sclerosing encapsulating peritonitis as a rare cause of intestinal obstruction after the treatment of peritoneal mesothelioma: a case report and review of the literature. Transl Cancer Res TCR. 2021;10:3074-80.
9. Ayoub M, Ouazni M, Achraf M, Sanae A, Mehdi S. Surgical management of sclerosing encapsulating peritonitis (SEP) secondary to tuberculosis: a case report and review of the literature. Int J Surg Case Rep. 2024;115:109292.
10. Osama M, Roy S, Rawat S, Rao S. IgG4 related sclerosing encapsulating peritonitis with cocoon formation: an unusual and undescribed presentation. Indian J Pathol Microbiol. 2022;65:683.
11. Koak Y, Gertner D, Forbes A, Ribeiro BF. Idiopathic sclerosing peritonitis. Eur J Gastroenterol Hepatol. 2008;20:148-50.
12. Mishra S, Chaudhary K, Tyagi S, Mishra P, Misra V. Primary sclerosing encapsulating peritonitis. Indian J Pathol Microbiol. 2023;67:182-4.
13. Yue B, Cui Z, Kang W, et al. Abdominal cocoon with bilateral cryptorchidism and seminoma in the right testis: a case report and review of literature. BMC Surg. 2019;19:167.
14. Alsadery HA, Busbait S, Alblowi A, Alsawidan M, Albisher HM, Alshammary S. Abdominal cocoon syndrome (idiopathic sclerosing encapsulating peritonitis): an extremely rare cause of small bowel obstruction—Two case reports and a review of literature. Front Med. 2022;9:1003775.
15. Machado NO. Sclerosing encapsulating peritonitis: review. Sultan Qaboos Univ Med J. 2016;16:e142-51.
16. Gao Q, Liang C, Liu Z. Clinical characteristics and imaging diagnosis of primary sclerosing encapsulating peritonitis. Int J Med Radiol. 2008;31:251-2.
17. Bozan MB, Kanat BH, Yazar FM, et al. A diagnostic dilemma for acute abdomen: sclerosing encapsulating peritonitis (abdominal cocoon syndrome); A retrospective cohort study. Arch Iran Med. 2021;24:447-52.
18. Duman E, Aslan A, Gunduz N, Inan I. Sclerosing encapsulated peritonitis: typical imaging findings for easy diagnosis. Ann Saudi Med. 2018;38:230-2.
19. Xu J, Wu X, Liu Ji, et al. Surgical treatment of 7 cases of sclerosing encapsulated peritonitis. Chin J Curr Adv Gen Surg. ;25:417-20. Available from: http://dianda.cqvip.com/Qikan/Article/Detail?id=7107328232 [Last accessed on 3 Jun 2026].
20. Wei F, Lin Z. Pay attention to the prevention and treatment of encapsulated sclerosing peritonitis. J Clin Nephrol. 2012;12:342-4.
21. Cheng B, Zhao D, Wu Y. Clinical characteristics and progress in diagnosis and treatment of abdominal cocoon. Chin J Dig. 2012;32:68-70.
22. Bozkurt D, Cetin P, Sipahi S, et al. The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis. Perit Dial Int. 2008;28:S38-42.
23. Koçak G, Azak A, Astarcı HM, et al. Effects of renin‐angiotensin‐aldosterone system blockade on chlorhexidine gluconate‐induced sclerosing encapsulated peritonitis in rats. Ther Apher Dial. 2012;16:75-80.
24. Wong CF, Beshir S, Khalil A, et al. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int. 2005;25:285-7.
25. Bozkurt D, Sipahi S, Cetin P, et al. Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis? Perit Dial Int. 2009;29:S206-10.
26. Lafrance J, Létourneau I, Ouimet D, et al. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis. 2008;51:e7-10.
27. Mondello S, Mazzon E, Di Paola R, et al. Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. Shock. 2009;32:332-9.
28. Sachdev A, Usatoff V, Thaow C. Sclerosing encapsulating peritonitis and methotrexate. Aust N Z J Obstet Gynaecol. 2006;46:58-9.
29. Bozkurt D, Bicak S, Sipahi S, et al. The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis. Perit Dial Int. 2008;28:S53-7.
30. Duman S, Bozkurt D, Sipahi S, et al. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model. Adv Perit Dial. 2008;24:104-10.
